Interested participants, please email us at firstname.lastname@example.org with your Name, Profession, Contact details and MCR number.
A/Prof Mark Chan, Senior Consultant, Department of Cardiology, NUHCS; and
Dr. Yap Eng Soo, Consultant, Deparment of Haematology- Oncology, NCIS
Title: Cardiovascular Disease in Women: Clinical Perspectives
Speaker: Dr. Chan Po Fun, Consultant, Department of Cardiology, NTFGH
All women face the threat of heart disease. Cardiovascular diseases are the leading cause of death amongst women, ahead of breast, uterine, and ovarian cancers. Gender-specific data have been increasing steadily, and a new understanding of gender-unique approaches has evolved in the diagnosis, treatment, and prevention of cardiovascular diseases. This talk discusses the facts, and dispels the myths of Women's Heart Health.
Title: Women in Atrial Fibrillation – Challenges in treatment
Speaker: Dr. Sim Hui Wen, Associate Consultant, Department of Cardiology, NUHCS
Atrial fibrillation (AF) is the most common arrhythmia worldwide and women are more likely than men to experience symptoms and to seek care. However, compared to men, women with AF have worse symptoms, quality of life and complications (stroke and mortality). In this talk we explore the sex differences in AF and the challenges in treating this population.
Title: Anticoagulation for heart disease in pregnancy catch-22
Speaker: Assistant Professor Low Ting Ting, Consultant, Department of Cardiology, NUHCS
Managing anticoagulation in pregnancy is a particularly knotty problem, having to balance between obstetric and cardiac risks plus maternal and fetal risks at varying degrees across the antepartum and peri-delivery period. This talk will look at the evolving strategies and recommended guidelines for cardiac disease in pregnancy.
Title: A Practical Approach to Hyperglycemia in Pregnancy and Beyond
Speaker: Assistant Professor Yew Tong Wei, Consultant, Division of Endocrinology, NUH
Gestational diabetes (GDM) is associated with increased maternal and fetal complications. About 1 in 5 pregnant women in Singapore develop GDM and this is among the highest in the world. The prevalence of diabetes is also increasing in Singapore, more women in their child bearing age are having pre-existing pregestational diabetes as they go through pregnancy. In this talk, these two hyperglycemic conditions in pregnancy, their diagnosis, complications and management principles will be discussed.
Title: Treatment of Cancer Associated Thrombosis
Speaker: Dr. Winnie Teo, Associate Consultant, Department of Haematology-Oncology, NCIS
Venous thromboembolism (VTE) contributes to significant morbidity and mortality in patients with cancer as they are at four times higher risk than the general population of developing serious VTE. VTE affects cancer treatment which in turn imposes economic and emotional burden in this patient population. This talk looks at latest updates in treatment of cancer associated thrombosis.
Title: Cancer and Atrial Fibrillation
Speaker: Dr. Yap Eng Soo, Consultant, Department of Haematology-Oncology, NCIS
Atrial fibrillation is the most common cardiac arrhythmia affecting 1.5-2% of the general population and this increases a further 1.8% in the presence of cancer. Anti-coagulation is an effective way to prevent embolic stroke but this is challenging in the cancer setting due to higher rates of bleeding. Cancer patients who receives chemotherapy have an increased risk of developing non-valvular atrial fibrillation. This talk discusses current evidence for anti-thrombotic therapy in non-valvular atrial fibrillation in cancer patients and the latest guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
Title: Cancer Therapies and the Heart
Speaker: Dr. Christopher Koo, Associate Consultant, Department of Cardiology, NUHCS
Modern day cancer therapies have rapidly advanced and changed many cancers from a terminal illness into a chronic disease. Many cancer patients often have concurrent cardiovascular disease, and many cancer therapies have been associated with cardiovascular toxicity. This talk discusses the major effects of various cancer therapies on the heart and proposed management options.
Title: VTE Prophylaxis in Cancer Patients
Speaker: Dr. Chee Yen Lin, Head and Senior Consultant, Department of Haematology-Oncology, NCIS
Cancer and its treatment are important risk factors for venous thromboembolism (VTE). However, the risk of VTE varies widely between cancer patients and the risk-benefit of routine pharmacological thromboprophylaxis is unclear particularly in ambulatory patients. This talk will summarise the evidence for VTE risk stratification in cancer patients and approaches to reducing this risk with thromboprophylaxis